Ovid Therapeutics Inc Working Capital to Net Assets Ratio
Ovid Therapeutics Inc working capital to net assets ratio. Ovid Therapeutics Inc (OVID) has a Working Capital to Net Assets ratio of 54.1% as of June 2026. Working capital of $113.64 Million (current assets of $123.62 Million minus current liabilities of $9.98 Million) is measured against net assets of $209.89 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Ovid Therapeutics Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Ovid Therapeutics Inc (2014–2025)
Working capital to net assets ratio of Ovid Therapeutics Inc from 2014 to 2025. This chart shows how Ovid Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2014 to 2025. As of June 2026, the ratio stands at 54.1%, reflecting working capital of $113.64 Million against net assets of $209.89 Million USD. See Ovid Therapeutics Inc (OVID) defensive interval to measure how many days the company can operate on defensive assets alone.
Ovid Therapeutics Inc Working Capital to Net Assets Ratio by Year (2014–2025)
Ovid Therapeutics Inc working capital to net assets ratio by year from 2014 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Ovid Therapeutics Inc from 2014 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Ovid Therapeutics Inc total assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 62.9% | $82.16 Million | $130.66 Million | $90.45 Million | $8.29 Million | ▼ -3.7 pp |
| 2024 | 66.6% | $45.42 Million | $68.23 Million | $55.94 Million | $10.52 Million | ▼ -45.2 pp |
| 2023 | 111.8% | $98.12 Million | $87.80 Million | $109.60 Million | $11.47 Million | ▲ +17.7 pp |
| 2022 | 94.0% | $124.39 Million | $132.27 Million | $131.38 Million | $6.99 Million | ▼ -3.7 pp |
| 2021 | 97.7% | $175.68 Million | $179.75 Million | $190.48 Million | $14.80 Million | ▼ -23.2 pp |
| 2020 | 121.0% | $52.78 Million | $43.63 Million | $74.84 Million | $22.06 Million | ▲ +22.0 pp |
| 2019 | 98.9% | $69.28 Million | $70.02 Million | $79.81 Million | $10.53 Million | ▲ +7.7 pp |
| 2018 | 91.3% | $35.42 Million | $38.81 Million | $44.27 Million | $8.84 Million | ▼ -7.7 pp |
| 2017 | 99.0% | $82.57 Million | $83.44 Million | $88.59 Million | $6.02 Million | ▲ +0.2 pp |
| 2016 | 98.7% | $48.68 Million | $49.29 Million | $52.41 Million | $3.73 Million | ▼ -1.1 pp |
| 2015 | 99.9% | $67.97 Million | $68.07 Million | $70.28 Million | $2.31 Million | ▲ +0.1 pp |
| 2014 | 99.8% | $4.73 Million | $4.74 Million | $4.85 Million | $119.95K | — |